Effective June 10, 2024, the Board of Directors of CareMax, Inc. appointed Mr. Paul Rundell, a Managing Director at Alvarez & Marsal North America, LLC (?A&M?), as Chief Restructuring Officer (?CRO?) of the Company. Mr. Rundell, age 49, is a Managing Director in A&M?s restructuring practice, where he focuses on clients in the healthcare industry. Mr. Rundell has been with A&M since 2008.

Prior to joining A&M, Mr. Rundell worked with several restructuring and interim management firms. Mr. Rundell has worked with numerous healthcare clients throughout the country, helping them navigate through financial and operational challenges, including serving as Interim Chief Executive Officer of 21st Century Oncology Holdings, Inc. from February 2017 through February 2018. Mr. Rundell is a Certified Insolvency and Restructuring Advisor (CIRA), a Certified Turnaround Professional (CTP) and a member of the Turnaround Management Association (TMA) and the Association of Insolvency and Restructuring Advisors (AIRA). Mr. Rundell holds a Bachelor?s Degree and a Master?s Degree in business administration from the University of Illinois.